 | Up a level |
Journal Article
Worst, Barbara C., van Tilburg, Cornelis M., Balasubramanian, Gnana Prakash, Fiesel, Petra, Witt, Ruth, Freitag, Angelika, Boudalil, Miream, Previti, Christopher, Wolf, Stephan, Schmidt, Sabine, Chotewutmontri, Sasithorn, Bewerunge-Hudler, Melanie, Schick, Matthias, Schlesner, Matthias 
ORCID: 0000-0002-5896-4086, Hutter, Barbara ORCID: 0000-0002-9034-0329, Taylor, Lenka, Borst, Tobias, Sutter, Christian, Bartram, Claus R., Milde, Till ORCID: 0000-0002-7267-1052, Pfaff, Elke, Kulozik, Andreas E., von Stackelberg, Arend, Meisel, Roland, Borkhardt, Arndt, Reinhardt, Dirk, Klusmann, Jan-Henning ORCID: 0000-0002-1070-0727, Fleischhack, Gudrun, Tippelt, Stephan, Dirksen, Uta, Juergens, Heribert, Kramm, Christof M., von Bueren, Andre O., Westermann, Frank, Fischer, Matthias, Burkhardt, Birgit, Wossmann, Wilhelm, Nathrath, Michaela, Bielack, Stefan S., Fruehwald, Michael C., Fulda, Simone ORCID: 0000-0002-0459-6417, Klingebiel, Thomas, Koscielniak, Ewa, Schwab, Matthias, Tremmel, Roman ORCID: 0000-0003-1564-0433, Driever, Pablo Hernaiz, Schulte, Johannes H., Brors, Benedikt ORCID: 0000-0001-5940-3101, von Deimling, Andreas ORCID: 0000-0002-5863-540X, Lichter, Peter, Eggert, Angelika, Capper, David ORCID: 0000-0003-1945-497X, Pfister, Stefan M., Jones, David T. W. and Witt, Olaf
(2016).
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Eur. J. Cancer, 65.
S. 91 - 102.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
van Tilburg, Cornelis M., Milde, Till, Witt, Ruth, Ecker, Jonas, Hielscher, Thomas, Seitz, Angelika, Schenk, Jens-Peter, Buhl, Juliane L., Riehl, Dennis, Fruhwald, Michael C., Pekrun, Arnulf, Rossig, Claudia, Wieland, Regina, Flotho, Christian, Kordes, Uwe, Gruhn, Bernd, Simon, Thorsten, Linderkamp, Christin, Sahm, Felix ORCID: 0000-0001-5441-1962, Taylor, Lenka, Freitag, Angelika, Burhenne, Jurgen, Foerster, Kathrin I., Meid, Andreas D., Pfister, Stefan M., Karapanagiotou-Schenkel, Irini and Witt, Olaf
(2019).
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
Clin. Epigenetics, 11 (1).
LONDON:
BMC.
ISSN 1868-7083
van Tilburg, Cornelis Martinus, Milde, Till, Witt, Ruth, Ecker, Jonas, Seitz, Angelika, Schenk, Jens-Peter, Fruehwald, Michael, Pekrun, Arnulf, Roessig, Claudia, Wieland, Regina, Flotho, Christian, Kordes, Uwe, Gruhn, Bernd, Simon, Thorsten, Linderkamp, Christin, Taylor, Lenka, Burhenne, Juergen, Pfister, Stefan M., Karapanagiotou-Schenkel, Irini and Witt, Olaf (2018). Phase 1/2 intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755